A federal judge in Boston ruled that the Trump administration cannot bar healthcare providers that receive certain federal HIV-treatment funds from acknowledging the gender identity of transgender patients or providing them gender-affirming care, according to Reuters.
US District Judge William Young sided with a group of national HIV medical associations and healthcare providers. The plaintiffs challenged grant funding conditions that the administration imposed last year after President Donald Trump signed an executive order prohibiting federal funding for what he calls "gender ideology."
The lawsuit, filed in June by groups including the American Academy of HIV Medicine, targets policies the US Department of Health and Human Services adopted for the Ryan White HIV/AIDS Program. Beginning in March, the Health Resources and Services Administration, a HHS division that runs the program, added conditions requiring that funding support activities using "sex-based definitions grounded in biological reality" and not "social or medical experimentation," the lawsuit said.
The plaintiffs argue the policy violates the Administrative Procedure Act. They say the changes conflict with the program's statutory mandate to provide comprehensive medical services to HIV patients, which has historically included hormone therapy for transgender people. They also argue the conditions discriminate based on transgender status and restrict doctors' speech, since they could not use patients' preferred pronouns.
Young, a Reagan appointee, urged the administration to settle at the end of a bench trial in September. According to an October 2 court filing, the administration rejected a settlement proposal from the plaintiffs.